Announcements Trials
Browse Landscape

Status

Completed 407Recruiting 105Terminated 74Unknown 73Active not recruiting 44Not yet recruiting 20Withdrawn 16Enrolling by invitation 5Suspended 2No longer available 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 10Sarcoma 2CNS 2NET 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 4Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Triple Negative Local Advanced Breast Cancer 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioblastoma 1Chordoma 1Chondrosarcoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasm Malignant Female 1Brain Neoplasms 1

Interventions

Proton Pump Inhibitors 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Neoplasms × Breast × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡